$2.59
0.01[0.39%]
At close: May 22
$2.59
0[0.00%]
After Hours: 4:00PM EDT
Standard BioTools
(NASDAQ:LAB)Standard BioTools Stock (NASDAQ:LAB), Quotes and News Summary
Standard BioTools Stock (NASDAQ: LAB) stock price, news, charts, stock research, profile.
| Open | $2.590 |
| Close | $2.590 |
| Volume / Avg. | 1.393M / 2.507M |
| Day Range | 2.535 - 2.660 |
| 52 Wk Range | 1.570 - 3.160 |
| Market Cap | $981.249M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 61 |
| Short Interest | 3.16% |
| Days to Cover | 3.9 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Standard BioTools (LAB) stock?
You can purchase shares of Standard BioTools (NASDAQ: LAB) through any online brokerage.
Who are Standard BioTools's (LAB) competitors?
Other companies in Standard BioTools’s space includes: 10x Genomics (NASDAQ:TXG), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Sotera Health (NASDAQ:SHC) and Olink Holding (NASDAQ:OLK).
What is the target price for Standard BioTools (LAB) stock?
The latest price target for Standard BioTools (NASDAQ: LAB) was reported by TD Cowen on Tuesday, April 16, 2024. The analyst firm set a price target for 3.50 expecting LAB to rise to within 12 months (a possible 35.14% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Standard BioTools (LAB)?
The stock price for Standard BioTools (NASDAQ: LAB) is $2.59 last updated Today at May 22, 2024 at 4:00 PM EDT.
Does Standard BioTools (LAB) pay a dividend?
There are no upcoming dividends for Standard BioTools.
When is Standard BioTools (NASDAQ:LAB) reporting earnings?
Standard BioTools’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
Is Standard BioTools (LAB) going to split?
There is no upcoming split for Standard BioTools.
What sector and industry does Standard BioTools (LAB) operate in?
Standard BioTools is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.